The blockade of the TGF-β pathway alleviates abnormal glucose and lipid metabolism of lipodystrophy not obesity.

MLA

Xu, Wen-Dong, et al. “The Blockade of the TGF-β Pathway Alleviates Abnormal Glucose and Lipid Metabolism of Lipodystrophy Not Obesity.” Pharmacology Research & Perspectives, vol. 12, no. 1, Feb. 2024, p. e1160. EBSCOhost, https://doi.org/10.1002/prp2.1160.

APA

Xu, W.-D., Lai, S.-Z., Zhao, J., Wei, S.-J., Fang, X.-Y., Liu, Y.-Y., Rong, X.-L., & Guo, J. (2024). The blockade of the TGF-β pathway alleviates abnormal glucose and lipid metabolism of lipodystrophy not obesity. Pharmacology Research & Perspectives, 12(1), e1160. https://doi.org/10.1002/prp2.1160

Chicago

Xu, Wen-Dong, Shui-Zheng Lai, Jia Zhao, Shi-Jie Wei, Xue-Ying Fang, Yi-Yi Liu, Xiang-Lu Rong, and Jiao Guo. 2024. “The Blockade of the TGF-β Pathway Alleviates Abnormal Glucose and Lipid Metabolism of Lipodystrophy Not Obesity.” Pharmacology Research & Perspectives 12 (1): e1160. doi:10.1002/prp2.1160.